Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

TherapeuticsMD, Inc. News

Sesen Bio Stock Skyrockets Ahead of FDA Bladder Cancer Drug Decision

Sesen Bio's stock climbs as the company says it expects to hear from the FDA next week.

TherapeuticsMD's Hormone Therapy Approved in U.K. and Belgium

TherapeuticsMD, a women’s healthcare company, received approval for its Bijuva hormone replacement therapy in the U.K. and Belgium.

Rally Runs Low on Fuel: Cramer's 'Mad Money' Recap

Cramer says rallies need fuel, and without it, we end up with what we got Tuesday: a soggy session that reminds us stocks can go down, too.

Yeti Holdings, Canopy Growth, Dermira: 'Mad Money' Lightning Round

Jim Cramer takes a look at Yeti Holdings, Canopy Growth, Dermira, Daktronics, TherapeuticsMD, Rite Aid, Genpact and California Water Services.

Box, Cummins, Verizon: 'Mad Money' Lightning Round

Jim Cramer is taking a closer look at Box, Cummins, Verizon, TherapeuticsMD, Morgan Stanley, Canopy Growth, Principal Financial and more.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.